BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 10703900)

  • 1. Adenosine mediates nitric-oxide-independent renal vasodilation by activation of A2A receptors.
    Rump LC; Jabbari-T J; von Kügelgen I; Oberhauser V
    J Hypertens; 1999 Dec; 17(12 Pt 2):1987-93. PubMed ID: 10703900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purinoceptors mediate renal vasodilation by nitric oxide dependent and independent mechanisms.
    Rump LC; Oberhauser V; von Kügelgen I
    Kidney Int; 1998 Aug; 54(2):473-81. PubMed ID: 9690214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of K+ channels in A2A adenosine receptor-mediated dilation of the pressurized renal arcuate artery.
    Prior HM; Yates MS; Beech DJ
    Br J Pharmacol; 1999 Jan; 126(2):494-500. PubMed ID: 10077243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The endothelium of the rat renal artery plays an obligatory role in A2 adenosine receptor-mediated relaxation induced by 5'-N-ethylcarboxamidoadenosine and N6-cyclopentyladenosine.
    Martin PL; Potts AA
    J Pharmacol Exp Ther; 1994 Sep; 270(3):893-9. PubMed ID: 7932201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of adenosine receptor agonists on guinea-pig isolated working hearts and the role of endothelium and NO.
    Maddock HL; Broadley KJ; Bril A; Khandoudi N
    J Pharm Pharmacol; 2002 Jun; 54(6):859-67. PubMed ID: 12079003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of multiple sites by adenosine analogues in the rat isolated aorta.
    Prentice DJ; Hourani SM
    Br J Pharmacol; 1996 Jul; 118(6):1509-17. PubMed ID: 8832079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine A2a receptors increase arterial endothelial cell nitric oxide.
    Li Jm; Fenton RA; Wheeler HB; Powell CC; Peyton BD; Cutler BS; Dobson JG
    J Surg Res; 1998 Dec; 80(2):357-64. PubMed ID: 9878338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional and molecular characterization of receptor subtypes mediating coronary microvascular dilation to adenosine.
    Hein TW; Wang W; Zoghi B; Muthuchamy M; Kuo L
    J Mol Cell Cardiol; 2001 Feb; 33(2):271-82. PubMed ID: 11162132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of NO-resistant relaxation induced by acetylcholine in rabbit renal arteries.
    Kwon SC
    J Vet Med Sci; 2001 Jan; 63(1):37-40. PubMed ID: 11217060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine A(2A) receptors mediate coronary microvascular dilation to adenosine: role of nitric oxide and ATP-sensitive potassium channels.
    Hein TW; Belardinelli L; Kuo L
    J Pharmacol Exp Ther; 1999 Nov; 291(2):655-64. PubMed ID: 10525085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P2u receptor-mediated release of endothelium-derived relaxing factor/nitric oxide and endothelium-derived hyperpolarizing factor from cerebrovascular endothelium in rats.
    You J; Johnson TD; Marrelli SP; Mombouli JV; Bryan RM
    Stroke; 1999 May; 30(5):1125-33. PubMed ID: 10229754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Requisite roles of A2A receptors, nitric oxide, and KATP channels in retinal arteriolar dilation in response to adenosine.
    Hein TW; Yuan Z; Rosa RH; Kuo L
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2113-9. PubMed ID: 15914631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine receptor subtypes and vasodilatation in rat skeletal muscle during systemic hypoxia: a role for A1 receptors.
    Bryan PT; Marshall JM
    J Physiol; 1999 Jan; 514 ( Pt 1)(Pt 1):151-62. PubMed ID: 9831723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple receptor subtypes and multiple mechanisms of dilation are involved in vascular network dilation caused by adenosine.
    Thengchaisri N; Miriel VA; Rivers RJ
    Microvasc Res; 2009 May; 77(3):356-63. PubMed ID: 19323977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide participates in the hypotensive effect induced by adenosine A2 subtype receptor stimulation.
    Stella L; Berrino L; Filippelli A; de Novellis V; Rossi F
    J Cardiovasc Pharmacol; 1995 Jun; 25(6):1001-5. PubMed ID: 7564326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms involved in increased sensitivity to adenosine A(2A) receptor activation and hypoxia-induced vasodilatation in porcine coronary arteries.
    Hedegaard ER; Nielsen BD; Mogensen S; Rembold CM; Frøbert O; Simonsen U
    Eur J Pharmacol; 2014 Jan; 723():216-26. PubMed ID: 24309216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A2A-adenosine receptor reserve for coronary vasodilation.
    Shryock JC; Snowdy S; Baraldi PG; Cacciari B; Spalluto G; Monopoli A; Ongini E; Baker SP; Belardinelli L
    Circulation; 1998 Aug; 98(7):711-8. PubMed ID: 9715864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged exposure to 5'-N-ethylcarboxamidoadenosine (NECA) does not affect the adenosine A2A-mediated vasodilation in porcine coronary arteries.
    Conti A; Lozza G; Monopoli A
    Pharmacol Res; 1997 Feb; 35(2):123-8. PubMed ID: 9175581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelium-dependent relaxation in isolated renal arteries of diabetic rabbits.
    Yousif MH; Cherian A; Oriowo MA
    Auton Autacoid Pharmacol; 2002 Apr; 22(2):73-82. PubMed ID: 12568124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early activation of the p42/p44MAPK pathway mediates adenosine-induced nitric oxide production in human endothelial cells: a novel calcium-insensitive mechanism.
    Wyatt AW; Steinert JR; Wheeler-Jones CP; Morgan AJ; Sugden D; Pearson JD; Sobrevia L; Mann GE
    FASEB J; 2002 Oct; 16(12):1584-94. PubMed ID: 12374781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.